SIN, Robin a Denisa ŠTRUNCOVÁ. Status epilepticus as a complication after COVID-19 mRNA-1273 vaccine: A case report. World Journal of Clinical Cases. PLEASANTON: BAISHIDENG PUBLISHING GROUP INC, 2021, roč. 9, č. 24, s. 7218-7223. ISSN 2307-8960. Dostupné z: https://dx.doi.org/10.12998/wjcc.v9.i24.7218.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Status epilepticus as a complication after COVID-19 mRNA-1273 vaccine: A case report
Autoři SIN, Robin (203 Česká republika) a Denisa ŠTRUNCOVÁ (203 Česká republika, garant, domácí).
Vydání World Journal of Clinical Cases, PLEASANTON, BAISHIDENG PUBLISHING GROUP INC, 2021, 2307-8960.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30218 General and internal medicine
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 1.534
Kód RIV RIV/00216224:14110/21:00124181
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.12998/wjcc.v9.i24.7218
UT WoS 000727979500031
Klíčová slova anglicky SARS-CoV-2; COVID-19; mRNA vaccine; Complication of vaccination; Status epilepticus; Case report
Štítky 14110131, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 3. 3. 2022 13:21.
Anotace
BACKGROUND We present a rare case of status epilepticus in a 56-year-old man which arose as a complication after vaccination with the coronavirus disease 2019 (COVID-19) mRNA-1273 vaccine. The patient's history included well-compensated secondary epilepsy. The root cause of the situation was a fever which had developed as a side effect of the vaccination. CASE SUMMARY A 56-year-old man received the first dose of mRNA-1273 vaccine against the severe acute respiratory syndrome-coronavirus-2. The vaccine was administered intramuscularly (100 mg, 0.5 mL). The next morning the man was found to be suffering from fever and headaches while at the same time experiencing general weakness. He lost consciousness suddenly and experienced generalized clonic seizures which turned into status epilepticus. When the Emergency Medical Service arrived the patient was unconscious with spontaneous breathing and generalized clonic seizures. It was necessary to administer diazepam repeatedly. It was also necessary to administer high doses of levetiracetam and temporary propofol. The status epilepticus was brought under control approximately 90 min after the patient's transport to the Emergency Department. A follow-up electroencephalogram no longer revealed abnormal indications of epileptic fit. The patient was temporarily hospitalized in the Intensive Care Unit and after seven days care was discharged without any further apparent effects. CONCLUSION There is currently no specific treatment against COVID-19. Therefore, the benefits of COVID-19 vaccine protection outweigh the risks.
VytisknoutZobrazeno: 28. 7. 2024 09:14